KLK3 and cancer: Satkunasivam et al. reported a 45% lower risk of cancer-specific mortality in patients who underwent RP than in those who did not receive local treatment after propensity-score-matching using several covariates, including the age, PSA level, tumor stage or grade, comorbidity index, or use of ADT [6].